S&P 500   4,014.87 (+1.10%)
DOW   32,624.87 (+0.71%)
QQQ   311.83 (+1.53%)
AAPL   159.92 (+1.44%)
MSFT   279.81 (+1.66%)
META   204.88 (+2.09%)
GOOGL   101.52 (+0.49%)
AMZN   99.85 (+2.68%)
TSLA   193.23 (+2.14%)
NVDA   269.17 (+1.92%)
NIO   9.86 (+7.17%)
BABA   100.17 (+1.80%)
AMD   95.80 (+1.31%)
T   18.95 (+1.23%)
F   11.94 (+2.93%)
MU   62.97 (+6.22%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   96.27 (+1.53%)
AMC   4.94 (-4.08%)
PFE   40.09 (+0.25%)
PYPL   73.84 (+1.57%)
NFLX   330.28 (+2.09%)
S&P 500   4,014.87 (+1.10%)
DOW   32,624.87 (+0.71%)
QQQ   311.83 (+1.53%)
AAPL   159.92 (+1.44%)
MSFT   279.81 (+1.66%)
META   204.88 (+2.09%)
GOOGL   101.52 (+0.49%)
AMZN   99.85 (+2.68%)
TSLA   193.23 (+2.14%)
NVDA   269.17 (+1.92%)
NIO   9.86 (+7.17%)
BABA   100.17 (+1.80%)
AMD   95.80 (+1.31%)
T   18.95 (+1.23%)
F   11.94 (+2.93%)
MU   62.97 (+6.22%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   96.27 (+1.53%)
AMC   4.94 (-4.08%)
PFE   40.09 (+0.25%)
PYPL   73.84 (+1.57%)
NFLX   330.28 (+2.09%)
S&P 500   4,014.87 (+1.10%)
DOW   32,624.87 (+0.71%)
QQQ   311.83 (+1.53%)
AAPL   159.92 (+1.44%)
MSFT   279.81 (+1.66%)
META   204.88 (+2.09%)
GOOGL   101.52 (+0.49%)
AMZN   99.85 (+2.68%)
TSLA   193.23 (+2.14%)
NVDA   269.17 (+1.92%)
NIO   9.86 (+7.17%)
BABA   100.17 (+1.80%)
AMD   95.80 (+1.31%)
T   18.95 (+1.23%)
F   11.94 (+2.93%)
MU   62.97 (+6.22%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   96.27 (+1.53%)
AMC   4.94 (-4.08%)
PFE   40.09 (+0.25%)
PYPL   73.84 (+1.57%)
NFLX   330.28 (+2.09%)
S&P 500   4,014.87 (+1.10%)
DOW   32,624.87 (+0.71%)
QQQ   311.83 (+1.53%)
AAPL   159.92 (+1.44%)
MSFT   279.81 (+1.66%)
META   204.88 (+2.09%)
GOOGL   101.52 (+0.49%)
AMZN   99.85 (+2.68%)
TSLA   193.23 (+2.14%)
NVDA   269.17 (+1.92%)
NIO   9.86 (+7.17%)
BABA   100.17 (+1.80%)
AMD   95.80 (+1.31%)
T   18.95 (+1.23%)
F   11.94 (+2.93%)
MU   62.97 (+6.22%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   96.27 (+1.53%)
AMC   4.94 (-4.08%)
PFE   40.09 (+0.25%)
PYPL   73.84 (+1.57%)
NFLX   330.28 (+2.09%)
NASDAQ:RCKT

Rocket Pharmaceuticals - RCKT Insider Trading & Ownership

$16.41
+0.62 (+3.93%)
(As of 03/29/2023 12:26 PM ET)
Add
Compare
Today's Range
$15.79
$16.52
50-Day Range
$15.79
$22.60
52-Week Range
$7.57
$23.48
Volume
249,344 shs
Average Volume
848,962 shs
Market Capitalization
$1.30 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.58

Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.67%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$20.00 M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$1.04 M

RCKT Insider Buying and Selling by Quarter

Get RCKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Rocket Pharmaceuticals Insider Trades History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/17/2023Gaurav ShahCEOSell12,194$19.06$232,417.64536,885  
2/17/2023Jonathan David SchwartzInsiderSell3,557$19.06$67,796.4294,546  
10/6/2022Rtw Investments, LpDirectorBuy1,355,932$14.75$19,999,997.0017,628,567  
3/30/2022Jonathan David SchwartzInsiderSell45,000$16.41$738,450.00  
(Data available from 1/1/2013 forward)












RCKT Insider Trading Activity - Frequently Asked Questions

Who is on Rocket Pharmaceuticals's Insider Roster?

The list of insiders at Rocket Pharmaceuticals includes Gaurav Shah, Jonathan David Schwartz, Kinnari Patel, and Rtw Investments, Lp. Learn more on insiders at RCKT.

What percentage of Rocket Pharmaceuticals stock is owned by insiders?

33.67% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings.

Which Rocket Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased RCKT shares in the last 24 months: Gaurav Shah ($381,480.00), and Rtw Investments, Lp ($19,999,997.00).

How much insider buying is happening at Rocket Pharmaceuticals?

Insiders have purchased a total of 1,377,932 RCKT shares in the last 24 months for a total of $20,381,477.00 bought.

Which Rocket Pharmaceuticals insiders have been selling company stock?

The following insiders have sold RCKT shares in the last 24 months: Gaurav Shah ($232,417.64), Jonathan David Schwartz ($806,246.42), and Rtw Investments, Lp ($29,021,750.00).

How much insider selling is happening at Rocket Pharmaceuticals?

Insiders have sold a total of 785,751 Rocket Pharmaceuticals shares in the last 24 months for a total of $30,060,414.06 sold.

This page (NASDAQ:RCKT) was last updated on 3/29/2023 by MarketBeat.com Staff